Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 12, 2011 Filed Dec 20, 2011 18:30 UTC Amendment |
Tapiero JacquesSVP&Pres., Emerging Markets
|
GiftCommon Stock | 3,787 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-062274 · doc4a.xml · nonDerivative · entry 1 Tapiero Jacques · CIK 0001479078 · SVP&Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,239 F1 · shares: This amendment is being filed to correct the number of securities reported as gifts on the original Form 4 filed on 10/3/11; a difference of 91 shares was inadvertently reported. Read SEC document |
| April 11, 2011 Filed Apr 12, 2011 19:30 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
SaleCommon Stock | 5,700 | $35.76 | $203,832.00 |
DisclosureSEC source: 0001209191-11-022593 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,707 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011. F2 · price: This transaction was executed in multiple trades at prices ranging from $35.73 to $35.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 11, 2011 Filed May 18, 2011 18:38 UTC |
Nobles AnneChief Eth/Cmpl Ofcr & SVP, ERM
|
GiftCommon Stock | 815 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-029324 · doc4.xml · nonDerivative · entry 2 Nobles Anne · CIK 0001462543 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 5,091 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| March 31, 2011 Filed Apr 4, 2011 17:21 UTC |
HOOVER R DAVIDDirector
|
GrantCommon Stock | 250 | $34.38 | $8,595.00 |
DisclosureSEC source: 0001209191-11-020875 · doc4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,155 Read SEC document |
| March 11, 2011 Filed Mar 14, 2011 20:11 UTC |
Lundberg Jan MEVP,Science&Tech and Pres. LRL
|
SaleCommon Stock | 11,000 | $34.86 | $383,460.00 |
DisclosureSEC source: 0001209191-11-017723 · doc4.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,352 Read SEC document |
| March 04, 2011 Filed Mar 8, 2011 20:15 UTC |
Tapiero JacquesSVP&Pres., Emerging Markets
|
SaleCommon Stock | 5,000 | $34.50 | $172,500.00 |
DisclosureSEC source: 0001209191-11-016224 · doc4.xml · nonDerivative · entry 1 Tapiero Jacques · CIK 0001479078 · SVP&Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,026 Read SEC document |
| February 28, 2011 Filed Mar 2, 2011 18:21 UTC |
HOOVER R DAVIDDirector
|
GrantCommon Stock | 249 | $34.43 | $8,573.07 |
DisclosureSEC source: 0001209191-11-014224 · doc4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,755 Read SEC document |
| February 24, 2011 Filed Feb 3, 2012 00:16 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 5,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-007193 · doc5.xml · nonDerivative · entry 1 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,000 Read SEC document |
| February 24, 2011 Filed Feb 3, 2012 00:24 UTC |
Rice Derica WEVP-Global Services and CFO
|
GiftCommon Stock | 39,461 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-007198 · doc5.xml · nonDerivative · entry 2 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 112,444 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| February 24, 2011 Filed Feb 3, 2012 00:24 UTC |
Rice Derica WEVP-Global Services and CFO
|
GiftCommon Stock | 39,461 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-007198 · doc5.xml · nonDerivative · entry 1 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 16, 2011 Filed Feb 17, 2011 21:34 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
SaleCommon Stock | 3,100 | $34.49 | $106,919.00 |
DisclosureSEC source: 0001209191-11-010612 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,407 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010. Read SEC document |
| February 15, 2011 Filed Feb 17, 2011 21:31 UTC |
Rice Derica WEVP-Global Services and CFO
|
SaleCommon Stock | 12,441 | $34.55 | $429,836.55 |
DisclosureSEC source: 0001209191-11-010609 · doc4.xml · nonDerivative · entry 1 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,461 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2009. F2 · price: This transaction was executed in multiple trades at prices ranging from $34.50 to $34.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 09, 2011 Filed Feb 10, 2011 20:13 UTC |
Deane Frank MPresident, Mfg. Operations
|
SaleCommon Stock | 23,435 | $35.75 | $837,801.25 |
DisclosureSEC source: 0001209191-11-008370 · doc4.xml · nonDerivative · entry 1 Deane Frank M · CIK 0001401222 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,124 Read SEC document |
| February 03, 2011 Filed Feb 3, 2011 22:55 UTC |
ARMITAGE ROBERT ASr. VP and General Counsel
|
SaleCommon Stock | 26 | $35.39 | $920.14 |
DisclosureSEC source: 0001209191-11-006870 · doc4.xml · nonDerivative · entry 12 ARMITAGE ROBERT A · CIK 0001233249 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,162 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 3, 2010. Read SEC document |
| February 03, 2011 Filed Feb 3, 2011 22:55 UTC |
ARMITAGE ROBERT ASr. VP and General Counsel
|
SaleCommon Stock | 1,500 | $35.38 | $53,070.00 |
DisclosureSEC source: 0001209191-11-006870 · doc4.xml · nonDerivative · entry 11 ARMITAGE ROBERT A · CIK 0001233249 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,188 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 3, 2010. Read SEC document |
| February 03, 2011 Filed Feb 3, 2011 22:55 UTC |
ARMITAGE ROBERT ASr. VP and General Counsel
|
SaleCommon Stock | 2,700 | $35.37 | $95,499.00 |
DisclosureSEC source: 0001209191-11-006870 · doc4.xml · nonDerivative · entry 10 ARMITAGE ROBERT A · CIK 0001233249 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,688 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 3, 2010. Read SEC document |
| February 03, 2011 Filed Feb 3, 2011 22:55 UTC |
ARMITAGE ROBERT ASr. VP and General Counsel
|
SaleCommon Stock | 10,546 | $35.36 | $372,906.56 |
DisclosureSEC source: 0001209191-11-006870 · doc4.xml · nonDerivative · entry 9 ARMITAGE ROBERT A · CIK 0001233249 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,388 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 3, 2010. Read SEC document |
| February 03, 2011 Filed Feb 3, 2011 22:55 UTC |
ARMITAGE ROBERT ASr. VP and General Counsel
|
SaleCommon Stock | 4,044 | $35.35 | $142,955.40 |
DisclosureSEC source: 0001209191-11-006870 · doc4.xml · nonDerivative · entry 8 ARMITAGE ROBERT A · CIK 0001233249 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,934 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 3, 2010. Read SEC document |
| February 03, 2011 Filed Feb 3, 2011 22:55 UTC |
ARMITAGE ROBERT ASr. VP and General Counsel
|
SaleCommon Stock | 2,394 | $35.34 | $84,603.96 |
DisclosureSEC source: 0001209191-11-006870 · doc4.xml · nonDerivative · entry 7 ARMITAGE ROBERT A · CIK 0001233249 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,978 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 3, 2010. Read SEC document |
| February 03, 2011 Filed Feb 3, 2011 22:55 UTC |
ARMITAGE ROBERT ASr. VP and General Counsel
|
SaleCommon Stock | 6,963 | $35.33 | $246,002.79 |
DisclosureSEC source: 0001209191-11-006870 · doc4.xml · nonDerivative · entry 6 ARMITAGE ROBERT A · CIK 0001233249 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,372 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 3, 2010. Read SEC document |
| February 03, 2011 Filed Feb 3, 2011 22:55 UTC |
ARMITAGE ROBERT ASr. VP and General Counsel
|
SaleCommon Stock | 5,821 | $35.32 | $205,597.72 |
DisclosureSEC source: 0001209191-11-006870 · doc4.xml · nonDerivative · entry 5 ARMITAGE ROBERT A · CIK 0001233249 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,335 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 3, 2010. Read SEC document |
| February 03, 2011 Filed Feb 3, 2011 22:55 UTC |
ARMITAGE ROBERT ASr. VP and General Counsel
|
SaleCommon Stock | 600 | $35.31 | $21,186.00 |
DisclosureSEC source: 0001209191-11-006870 · doc4.xml · nonDerivative · entry 4 ARMITAGE ROBERT A · CIK 0001233249 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,156 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 3, 2010. Read SEC document |
| February 03, 2011 Filed Feb 3, 2011 22:55 UTC |
ARMITAGE ROBERT ASr. VP and General Counsel
|
SaleCommon Stock | 600 | $35.30 | $21,180.00 |
DisclosureSEC source: 0001209191-11-006870 · doc4.xml · nonDerivative · entry 3 ARMITAGE ROBERT A · CIK 0001233249 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,756 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 3, 2010. Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 22:55 UTC |
ARMITAGE ROBERT ASr. VP and General Counsel
|
Exercise / conversionRestricted Stock Unit · Derivative | 55,294 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-006870 · doc4.xml · derivative · entry 17 ARMITAGE ROBERT A · CIK 0001233249 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 55,294 shares Expires 2011-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 22:55 UTC |
ARMITAGE ROBERT ASr. VP and General Counsel
|
Exercise / conversionCommon Stock | 55,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-006870 · doc4.xml · nonDerivative · entry 2 ARMITAGE ROBERT A · CIK 0001233249 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 22:55 UTC |
ARMITAGE ROBERT ASr. VP and General Counsel
|
Tax withholdingCommon Stock | 20,100 | $34.77 | $698,877.00 |
DisclosureSEC source: 0001209191-11-006870 · doc4.xml · nonDerivative · entry 1 ARMITAGE ROBERT A · CIK 0001233249 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,062 Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 22:56 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
Exercise / conversionRestricted Stock Unit · Derivative | 82,942 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-006873 · doc4.xml · derivative · entry 4 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 82,942 shares Expires 2011-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 22:56 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
Tax withholdingCommon Stock | 31,555 | $34.77 | $1,097,167.35 |
DisclosureSEC source: 0001209191-11-006873 · doc4.xml · nonDerivative · entry 2 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,507 Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 22:56 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
Exercise / conversionCommon Stock | 82,942 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-006873 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,062 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 22:58 UTC |
Deane Frank MPresident, Mfg. Operations
|
Exercise / conversionRestricted Stock Unit · Derivative | 35,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-006878 · doc4.xml · derivative · entry 4 Deane Frank M · CIK 0001401222 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,250 shares Expires 2011-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 22:58 UTC |
Deane Frank MPresident, Mfg. Operations
|
Tax withholdingCommon Stock | 11,815 | $34.77 | $410,807.55 |
DisclosureSEC source: 0001209191-11-006878 · doc4.xml · nonDerivative · entry 2 Deane Frank M · CIK 0001401222 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,559 Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 22:58 UTC |
Deane Frank MPresident, Mfg. Operations
|
Exercise / conversionCommon Stock | 35,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-006878 · doc4.xml · nonDerivative · entry 1 Deane Frank M · CIK 0001401222 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 23:00 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 207,354 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-006881 · doc4.xml · derivative · entry 7 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 207,354 shares Expires 2011-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 23:00 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
Tax withholdingCommon Stock | 83,114 | $34.77 | $2,889,873.78 |
DisclosureSEC source: 0001209191-11-006881 · doc4.xml · nonDerivative · entry 2 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,976 Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 23:00 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
Exercise / conversionCommon Stock | 207,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-006881 · doc4.xml · nonDerivative · entry 1 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,090 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 23:02 UTC |
Lundberg Jan MEVP,Science&Tech and Pres. LRL
|
Exercise / conversionRestricted Stock Unit · Derivative | 33,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-006885 · doc4.xml · derivative · entry 4 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,667 Underlying: Common Stock · 33,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Restricted Stock Units vests in three equal annual installments as follows: 33,333 on February 1, 2011; 33,333 on February 1, 2012; and 33,334 on February 1, 2013. F1 · derivative.expiration_date: The Restricted Stock Units vests in three equal annual installments as follows: 33,333 on February 1, 2011; 33,333 on February 1, 2012; and 33,334 on February 1, 2013. Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 23:02 UTC |
Lundberg Jan MEVP,Science&Tech and Pres. LRL
|
Tax withholdingCommon Stock | 10,981 | $34.77 | $381,809.37 |
DisclosureSEC source: 0001209191-11-006885 · doc4.xml · nonDerivative · entry 2 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,352 Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 23:02 UTC |
Lundberg Jan MEVP,Science&Tech and Pres. LRL
|
Exercise / conversionCommon Stock | 33,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-006885 · doc4.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 23:05 UTC |
Rice Derica WEVP-Global Services and CFO
|
Exercise / conversionRestricted Stock Unit · Derivative | 82,942 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-006887 · doc4.xml · derivative · entry 6 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 82,942 shares Expires 2011-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 23:05 UTC |
Rice Derica WEVP-Global Services and CFO
|
Tax withholdingCommon Stock | 31,040 | $34.77 | $1,079,260.80 |
DisclosureSEC source: 0001209191-11-006887 · doc4.xml · nonDerivative · entry 2 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,902 Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 23:05 UTC |
Rice Derica WEVP-Global Services and CFO
|
Exercise / conversionCommon Stock | 82,942 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-006887 · doc4.xml · nonDerivative · entry 1 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2011 Filed Feb 2, 2011 17:41 UTC |
HOOVER R DAVIDDirector
|
GrantCommon Stock | 247 | $34.79 | $8,593.13 |
DisclosureSEC source: 0001209191-11-006279 · doc4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,506 Read SEC document |
| January 25, 2011 Filed Jan 27, 2011 22:53 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
GrantCommon Stock | 19,657 | $34.73 | $682,687.61 |
DisclosureSEC source: 0001209191-11-005316 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,895 Read SEC document |
| January 25, 2011 Filed Jan 27, 2011 23:02 UTC |
Mahony SusanSVP, HR & Diversity
|
GrantCommon Stock | 9,297 | $34.73 | $322,884.81 |
DisclosureSEC source: 0001209191-11-005325 · doc4.xml · nonDerivative · entry 2 Mahony Susan · CIK 0001463321 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,543 Read SEC document |
| January 25, 2011 Filed Jan 27, 2011 23:02 UTC |
Mahony SusanSVP, HR & Diversity
|
GrantCommon Stock | 1,730 | $34.73 | $60,082.90 |
DisclosureSEC source: 0001209191-11-005325 · doc4.xml · nonDerivative · entry 1 Mahony Susan · CIK 0001463321 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 3,276 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| January 25, 2011 Filed Jan 27, 2011 23:03 UTC |
HANISH ARNOLD CChief Accounting Officer
|
GrantCommon Stock | 3,415 | $34.73 | $118,602.95 |
DisclosureSEC source: 0001209191-11-005326 · doc4.xml · nonDerivative · entry 1 HANISH ARNOLD C · CIK 0001233253 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,666 Read SEC document |
| January 25, 2011 Filed Jan 27, 2011 23:05 UTC |
Nobles AnneChief Eth/Cmpl Ofcr & SVP, ERM
|
GrantCommon Stock | 12,869 | $34.73 | $446,940.37 |
DisclosureSEC source: 0001209191-11-005329 · doc4.xml · nonDerivative · entry 1 Nobles Anne · CIK 0001462543 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,937 Read SEC document |
| January 25, 2011 Filed Jan 27, 2011 23:07 UTC |
Simmons Jeffrey NSVP&Pres.,Elanco Animal Health
|
GrantCommon Stock | 15,694 | $34.73 | $545,052.62 |
DisclosureSEC source: 0001209191-11-005332 · doc4.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,458 Read SEC document |
| January 25, 2011 Filed Jan 27, 2011 23:09 UTC |
Tapiero JacquesSVP&Pres., Emerging Markets
|
GrantCommon Stock | 16,670 | $34.73 | $578,949.10 |
DisclosureSEC source: 0001209191-11-005336 · doc4.xml · nonDerivative · entry 1 Tapiero Jacques · CIK 0001479078 · SVP&Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,026 Read SEC document |
| January 25, 2011 Filed Jan 27, 2011 23:11 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
GrantRestricted Stock Unit · Derivative | 87,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005340 · doc4.xml · derivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,924 Underlying: Common Stock · 87,924 shares Expires 2012-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.